Vectura Group PLC (LON:VEC) insider Andrew Derodra purchased 211 shares of the company’s stock in a transaction that occurred on Wednesday, February 14th. The shares were purchased at an average cost of GBX 71 ($0.98) per share, with a total value of £149.81 ($206.98).
Andrew Derodra also recently made the following trade(s):
- On Wednesday, January 17th, Andrew Derodra acquired 127 shares of Vectura Group stock. The shares were bought at an average price of GBX 118 ($1.63) per share, for a total transaction of £149.86 ($207.05).
- On Friday, December 8th, Andrew Derodra acquired 153 shares of Vectura Group stock. The shares were bought at an average price of GBX 98 ($1.35) per share, for a total transaction of £149.94 ($207.16).
Shares of Vectura Group PLC (LON:VEC) opened at GBX 77.35 ($1.07) on Thursday. Vectura Group PLC has a fifty-two week low of GBX 70.50 ($0.97) and a fifty-two week high of GBX 166.97 ($2.31).
TRADEMARK VIOLATION WARNING: This article was originally reported by American Banking News and is the property of of American Banking News. If you are viewing this article on another website, it was stolen and republished in violation of U.S. & international trademark and copyright laws. The correct version of this article can be accessed at https://www.americanbankingnews.com/2018/02/15/vectura-group-plc-vec-insider-buys-149-81-in-stock.html.
About Vectura Group
Vectura Group plc is engaged in research, development and commercialization of therapeutic products and drug delivery systems for human use. The Company’s products include Ultibro Breezhaler (European Union (EU) and Rest of World (RoW)) – LABA-LAMA; Seebri Breezhaler (EU and RoW) – LAMA; AirFluSal Forspiro (EU and RoW) – ICS-LABA; ADVATE (Global) – Antihaemophilic Factor (Recombinant); Adept (Global) – Icodextrin; Anoro Ellipta (Global) – LAMA-LABA; Relvar Ellipta/Breo Ellipta (Global) – ICS-LABA, and Incruse Ellipta (Global) – LAMA.
Receive News & Ratings for Vectura Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vectura Group and related companies with MarketBeat.com's FREE daily email newsletter.